Xopenex HFA (Sunovion Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Xopenex HFA drug offered from Sunovion Pharmaceuticals Inc.. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sunovion Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | levalbuterol tartrate |
| SUBSTANCE NAME: | LEVALBUTEROL TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | AEROSOL, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-12-01 |
| END MARKETING DATE: | 0000-00-00 |
Xopenex HFA HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xopenex HFA from Sunovion Pharmaceuticals Inc. |
| LABELER NAME: | Sunovion Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 45(ug/1) |
| START MARKETING DATE: | 2005-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63402-510_2cec95ae-bb6d-419e-acde-e1bbbb44b5b4 |
| PRODUCT NDC: | 63402-510 |
| APPLICATION NUMBER: | NDA021730 |
Other LEVALBUTEROL TARTRATE Pharmaceutical Manufacturers / Labelers:
